Nov 272023
Date |
Brand Name(s) |
Description |
Type |
Reason |
Company |
| 27-Nov-2023 | Novartis | Sandimmune (cyclosporine oral solution, USP) Oral Solution 100 mg/mL | Drugs | Due to crystallization formation | Novartis Pharmaceuticals Corporation |
Sorry, the comment form is closed at this time.